Uni-Bio Science Group Limited reported earnings results for the full year ended December 31, 2022. For the full year, the company reported sales was HKD 440.32 million compared to HKD 353.41 million a year ago. Net income was HKD 38.51 million compared to net loss of HKD 19.59 million a year ago.

Basic earnings per share from continuing operations was HKD 0.0061 compared to basic loss per share from continuing operations of HKD 0.0031 a year ago. Diluted earnings per share from continuing operations was HKD 0.0061 compared to diluted loss per share from continuing operations of HKD 0.0031 a year ago.